Mandate

Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm

May 09, 2011

Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm and Nordic Capital's offering of shares in connection therewith. Expected start of trading is on May 20, 2011. Handelsbanken Capital Markets and Carnegie Investment Bank are Joint Lead Managers and Joint Book Runners in the offering.

Vinge's project team is composed primarily of Göran Nyström, Pontus Enquist, Dain Nevonen and Christoffer Benninge as well as Lennart Larsson and Lina Hansson regarding tax matters.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026

Vinge has advised IK Partners in connection with the acquisition of Selatek

Vinge has advised IK Partners (“IK”) in connection with IK X Fund’s acquisition of SELATEK Holding AB (“Selatek”), a leading Swedish technical installation platform, from Amplio Private Equity AB and the minority shareholders.
April 20, 2026